Loading insider details...
Latest Form 4 (Nov 3, 2026): Exercise/Conversion of 1,929 REGN shares, $1.40M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 3, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,929 | $1.40M |
| Jan 6, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 155 | n/a |
| Jan 6, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 166 | n/a |
| Jun 17, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,535 | $960.3K |
| May 29, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,172 | $733.2K |
| Jan 4, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 135 | n/a |
| Dec 29, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 2,049 | $989.0K |
| Apr 24, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 3,070 | $1.60M |
| Feb 8, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 3,071 | $1.60M |
| Jan 30, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1 | $520.01 |